Objective To study the effect of Modified Buzhong Yiqi Decoction and acupoint application in the treatment of patients with overactive bladders. Methods Ninety-one female patients with overactive bladders treated at Department of Urology, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine from January 2022 to March 2024 were selected for the randomized controlled trial, and were divided into an experimental group (30 case), a control group 1 (30 cases), and a control group 2 (31 cases) by the random number table method. The experimental group were (46.72±10.13) years old, with a disease course of (3.09±2.49) years. The control group 1 were (46.98±11.29) years old, with a disease course of (3.18±2.63) years. The control group 2 were (47.48±10.11) years old, with a disease course of (3.08±2.44) years. The experimental group were treated by modified Buzhong Yiqi Decoction and acupoint application, the control group 1 with solifenacin succinate, and the control group 2 with modified Buzhong Yiqi Decoction, for 12 weeks. The urination diary (urination times during day time and night, urgency to urinate, and urge incontinence), scores of life quality, and overactive bladder syndrome scores (OABSS) before the treatment and after 12 weeks' treatment, clinical efficacies, and incidence rates of adverse reactions were compared between the 3 groups. t and χ2 tests were used for the statistical analysis. Results The urination times during day time and night and times of urgency to urinate and urge incontinence in 24 h, OABSS, and scores of life quality before the treatment and after 12 weeks' treatment in the experimental group were (14.4±1.57) times, (3.5±0.71) times, (3.5±0.53) times, (2.5±0.53) times, 9.7±1.16, 3.9±0.88, (10.1±1.10) times, (2.1±0.57) times, (1.9±0.57) times, (1.2±0.42) times, 4.4±1.26, and 1.7±0.68; those in the control group 1 were (14.3±2.00) times, (3.5±0.53) times, (3.5±0.85) times, (2.4±0.52) times, 9.9±0.99, 3.9±0.74, (10.3±2.05) times, (2.3±0.48) times, (2.1±0.88) times, (1.2±0.42) times, 4.9±1.29, and 2.1±0.57; those in the control group 2 were (14.1±2.02) times, (3.5±0.97) times, (3.5±1.08) times, (2.6±0.52) times, 10.0±1.76, 3.6±0.84, (11.6±1.83) times, (2.6±0.70) times, (2.3±0.95) times, (1.7±0.48) times, 5.9±1.19, and 2.6±0.84; there were statistical differences in the above indicators between before and after the treatment in the 3 groups (t=20.146, 8.573, 9.798, 8.510, 17.667, 7.571, 26.833, 9.192, 8.571, 9.833, 16.842, 10.554, 11.180, 5.014, 4.649, 7.090, 9.462, and 4.610; all P0.05). The total effective rates of the experimental group, the control group 1, and the control group 2 were 83.3% (25/30), 76.7% (23/30), and 51.6% (16/31), with a statistical difference between the 3 groups (χ2=8.213; P=0.016). No serious adverse reactions occurred in the three groups, with good tolerance. Conclusion Modified Buzhong Yiqi Decoction combined with acupoint application for patients with overactive bladders is effective and safe and can improve their treatment compliance.